First Phase III Depression Data For Intra-Cellular’s Caplyta Exceed Expectations

Add-On To Schizophrenia, Bipolar Depression Indications

Depiction of fear, loneliness, depression, abuse, addiction
Lumateperone met the primary and secondary endpoints in MDD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D